透析室の感染対策まるわかりBOOK

出版社： ヴァンメディカル
著者：
発行日： 2023-04-25
分野： 臨床医学：内科  >  感染症/AIDS
ISBN： 9784860921514
電子書籍版： 2023-04-25 （初版）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：約3営業日

2,530 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

2,530 円(税込)

購入する

商品紹介

標準予防策と対比させながら、違いと透析室の特別な感染対策をわかりやすく説明
患者さんと医療スタッフを守るために、基本的な考え方と具体的な予防策を提示
内容の要点をまとめたPOINTと詳細な解説を加えたMEMOで理解度がさらにアップ
「こんな本が欲しかった」にお答えする透析室の感染対策を丸ごとカバーした決定版

目次

  • 第1章　感染対策の基礎知識
    1.『感染対策』の考え方
    2.『標準予防策』の考え方
    3.『感染経路と感染経路別対策』の考え方
    4.『手指衛生』の考え方
    5.『個人防護具』の考え方
    6.『環境清掃』の考え方

    第2章　透析室の基礎知識
    1．透析室とは？～感染対策のために知っておくべき基礎知識～
    2．透析室の特殊性
    3．透析処置における手指衛生
    4．透析処置における個人防護具
    5．透析処置における環境整備

    第3章　透析処置とその感染対策
    1．透析の準備
    2．透析の開始
    3．透析中の管理
    4．透析の終了
    5．透析後の処理
    6．透析カテーテルの取り扱い

    第4章　透析室の病原体とその感染対策
    1．透析処置・透析患者に関わる病原体
    2．B型肝炎ウイルス（HBV）
    3．C型肝炎ウイルス（HCV）
    4．ヒト免疫不全ウイルス（HIV）
    5．インフルエンザウイルス
    6．ノロウイルス
    7．結核菌
    8．多剤耐性菌

    第5章　医療従事者のワクチン・患者のワクチン
    1.　ワクチンについて
    2．透析室におけるワクチンとその重要性
    3．HBVワクチン
    4．インフルエンザワクチン
    5．肺炎球菌ワクチン
    6．COVID-19ワクチン

    第6章　血液・体液曝露とその対策
    1．透析室における曝露リスク
    2．曝露直後の対応
    3．曝露後の患者の評価
    4．曝露の状況の評価
    5．曝露後の対応
    6．針刺しが発生した場合の曝露した人への生活指導
    7．曝露の報告

    第7章　透析医療器材の再生処理（洗浄・消毒・滅菌）
    1．透析医療器材の分類
    2．洗浄・消毒・滅菌の考え方とその方法
    3．使用済み器材の処理と回収

    第8章　透析室に必要な感染対策の啓発
    1．医療従事者への啓発
    2．患者への啓発

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 感染対策の基礎知識

P.27 掲載の参考文献
1) CDC:Guidelines for isolation precautions in hospitals, 1996. https://wonder.cdc.gov/wonder/prevguid/p0000419/p0000419.asp
 
2) CDC:Guideline for isolation precaution:Preventing transmission of infectious agents in healthcare settings, 2007. https://www.cdc.gov/infectioncontrol/pdf/guidelines/isolation-guidelines.pdf
PubMed
3) CDC:Recommendations for preventing transmission of infections among chronic hemodialysis patients. https://www.cdc.gov/mmwr/PDF/rr/rr5005.pdf
 
4) CDC:Guideline for hand hygiene in health-care settings. http://www.cdc.gov/mmwr/PDF/rr/rr5116.pdf
 
5) CDC:NIOSH Science Blog:N95 respirators and surgical masks. https://blogs.cdc.gov/niosh-science-blog/2009/10/14/n95/
 
6) CDC:Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. http://www.cdc.gov/mmwr/PDF/rr/rr5417.pdf
 
7) CDC:Guideline for environmental infection control in health-care facilities, 2003. https://www.cdc.gov/infectioncontrol/pdf/guidelines/environmental-guidelines.pdf
 

第2章 透析室の基礎知識

P.45 掲載の参考文献
1) Syed-Ahmed M et al:Immune dysfunction and risk of infection in chronic kidney disease. Adv Chronic Kidney Dis 26(1):8-15, 2019
PubMed
2) Vaziri ND et al:Effect of uremia on structure and function of immune system. J Ren Nutr 22(1):149-156, 2012
PubMed
3) Reddy S et al:Vaccination in chronic kidney disease. Adv Chronic Kidney Dis 26(1):72-78, 2019
PubMed
4) 花房規男ほか:わが国の慢性透析療法の現況(2020年12月31日現在). 透析会誌 54(12):611-657, 2021
 
5) 新田孝作:わが国の慢性透析療法の現況(2017年12月31日現在). 透析会誌51(12):699-766, 2018
 
6) 菊地 勘:新型コロナウイルスと血液透析(1)透析患者における新型コロナウイルスの総論-都内の感染状況と対策を含めて-. 透析会誌55(2):7-77, 2022
 
7) Weinhandl ED et al:Initial effects of COVID-19 on patients with ESKD. J Am Soc Nephrol 32(6):1444-1453, 2021
PubMed
8) Perl J et al:COVID-19 among adults receiving home verus in-center dialysis. Clin J Am Soc Nephrol 16(9):1410-1412, 2021
 
9) Cozzolino M et al:COVID-19 pandemic era:is it time to promoto home dialysis and peritoneal dialysis? Clin Kidney J 14 Suppl1:i6-i13, 2021
 
10) CDC:Recommendations for preventing transmission of infections among chronic hemodialysis patients. http://www.cdc.gov/mmwr/PDF/rr/rr5005.pdf
 
11) WHO Guidelines on hand hygiene in health care. http://whqlibdoc.who.int/publications/2009/9789241597906_eng.pdf
 
12) Mc Bride ME:Microbial flora of in-use soap products. Appl Environ Microbiol 48(2):338-341, 1984
PubMed
13) Parry MF et al:Candida osteomyelitis and diskitis after spinal surgery:an outbreak that implicates artificial nail use. Clin Infect Dis 32(3):352-357, 2001
PubMed
14) Passaro DJ et al:Postoperative Serratia marcescens wound infections treated to an out-of-hospital source. J Infect Dis 175(4):992-995, 1997
 
15) Lin CM et al:A comparison of hand washing techniques to remove Escherichia colli and calciviruses under natural or artificial fingernails. J Food Prot 66(12):2296-2301, 2003
PubMed
16) Foca M et al:Endemic Pseoudomonas aeruginosa infection in a neonatal intensive care unit. N Eng J Med 343(10):695-700, 2000
 
17) Larson E:Hygiene of the skin:when is clean too clean? Emerg Infect Dis 7(2):225-230, 2001
PubMed
18) Rocha LA et al:Changes in hands microbiota associated with skin damage because of hand hygiene procedures on the health care workers. Am J Infect Control 37(2):155-159, 2009
PubMed
19) Larson E:Skin hygiene and infection prevention:more of the same or different approaches? Clin Infect Dis 29(5):1287-1294, 1999
 
20) Alfurayh O et al:Hand contamination with hepatitis C virus in staff looking after hepatitis C-positive hemodialysis patients. Am J Nephrol 20(2):103-106, 2000
PubMed
21) Thompson ND et al:Patient-to patient hepatitis C virus transmissions associated with infection control breaches in a hemodialysis unit. J Nephrol Therapeutic S10:002, 2012
 
22) Girou E et al:Determinant roles of environmental contamination and noncompliance with standard precautions in the risk of hepatitis C virus transmission in a hemodialysis unit. Clin Infect Dis 47(5):627-633, 2008
 
23) Thompson ND et al:Hepatitis C virus transmission in hemodialysis units:importance of infection control practices and aseptic technique. Infect Control Hosp Epidemiol 30(9):900-903, 2009
PubMed
24) Furusho N et al:Confirmation of nosocomical hepatitis C virus infection in a hemodialysis unit. Infect Control Hosp Epidemiol 25(7):584-590, 2004
 
25) Senatore S et al:Hepatitis C virus outbreak in a haemodialysis unit:learning from failures. J Hosp Infect 94(3):249-252, 2016
 
26) Nguyen DB et al:A large outbreak of hepatitis C virus infections in a hemodialysis clinic. Infect Control Hosp Epidemiol 37(2):125-133, 2016
 
27) Puro V et al:Risk of exposure to bloodborne infection for Italian healthcare workers, by job category and work area. Infect Control Hosp Epidemiol 22(4):206-210, 2001
PubMed
28) Girou E et al:Determinant roles of environmental contamination and noncompliance with standard precautions in the risk of hepatitis C virus transmission in a hemodialysis unit. Clin Infect Dis 47(5):627-633, 2008
 
29) Siegel JD et al:2007 guideline for isolation precautions:preventing transmission of infectious agents in health care settings. Am J Infect Control 35(10 Suppl 2):S65-S164, 2007
 
30) 厚生労働科学特別研究事業「腎臓病・透析患者におけるCOVID-19対策の全国調査および易感染性・重症化因子の後方視的解析」研究班:血液透析患者のCOVID-19予防・診療体制調査 結果報告書(2021年2月22日) http://www.touseki-ikai.or.jp/htm/03_info/doc/20210224_poll_report1.pdf
 
31) Centers for Disease Control and Prevention:Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep 50(RR-5):1-43, 2001
 
32) KDIGO Clinical Practice Guidelines for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease:Guideline 3:Preventing HCV transmission in hemodialysis units. Kidney Int 73(Suppl 109):S46-S52, 2008
 
33) 社団法人日本透析医学会:透析患者のC型ウイルス肝炎治療ガイドライン. 透析会誌 44(6):481-531, 2011
 
34) Jadoul M et al:Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients. Kidney Int 95(4):939-947, 2019
PubMed
35) Kizny Gordon AE et al:The hospital water environment as a reservoir for carbapenem-resistant organisms causing hospital-acquired infections-a systemic review of the literature. Clin Infect Dis 64(10):1435-1444, 2017
 
36) Rebmann T et al:Preventinng infections in hemodialysis:An executive summary of APIC Elimination Guide. Am J Infect Control 39(1):72-75, 2011
PubMed
37) Kamili S et al:Infectivity of hepatitis C virus in plasma after drying and storing at room temperature. Infect Control Hosp Epidemiol 28(5):519-524, 2007
PubMed
38) Doerrbecker J et al:Inactivation and survival of hepatitis C virus on inanimate surfaces. J Infect Dis 204(12):1830-1838, 2011
PubMed
39) Paintsil E et al:Hepatitis C virus maintains infectivity for weeks after drying on inanimate surfaces at room temperature:implications for risks of transmission. J Infect Dis 209(8):1205-1211, 2014
PubMed
40) Paintsil E et al:Survival of hepatitis C virus in syringes:implication for transmission among injection drug users. Infect Dis 202(7):984-990, 2010
PubMed
41) Ciesek S et al:How stable is the hepatitis C virus(HCV)? Environmental stability of HCV and its susceptibility to chemical biocides. J Infect Dis 201(12):1859-1866, 2010
PubMed

第3章 透析処置とその感染対策

P.81 掲載の参考文献
1) Rebmann T et al:Preventinng infections in hemodialysis:An executive summary of APIC Elimination Guide. Am J Infect Control 39(1):72-75, 2011
PubMed
2) Okada J et al:Effectiveness of hand hygiene depends on the patient's health condition and care environment. Jap J Nurs Sci 13(4):413-423, 2016
 
3) Tokars JI et al:New national surveillance system for hemodialysis-associated infections:initial results. Am J Infect Control 30(5):288-295, 2002
PubMed
4) 戸塚恭一:針刺し事故防止に向けて. 感染症誌 76(10):849-850, 2002
 
5) Tuma S et al:Efficacy of safety-engineered device implementation in the prevention of percutaneous injuries:a review of published studies. Clin infect Dis 42(8):1159-1170, 2006
PubMed
6) Roff M et al:Do active safety-needle devices cause spatter contamination? J Hosp Infect 86(3):221-223, 2014
PubMed
7) 秋澤忠男:穿刺針および血液回路固定方法と抜針に関する実態調査報告. 日透析医会誌 22(2):13-47, 2007
 
8) Henderson DK:Managing occupational risks for hepatitis C transmission in the health care setting. Clin Microbiol Rev 16(3):546-568, 2003
PubMed
9) 2011年版 社団法人日本透析医学会「慢性血液透析用バスキュラーアクセスの作製および修復に関するガイドライン」. 透析会誌 44(9):855-937, 2011
 
10) Neely AN et al:Survival of enterococci and staphylococci on hospital fabrics and plastic. J Clin Microbiol 38(2):724-726, 2000.
PubMed
11) Hanczvikkel A et al:Quantitative study about the role of environmental conditions in the survival capability of multidrug-resistant bacteria. J Infect Public Health 11(6):801-806, 2018
PubMed
12) Neely AN et al:Survival of some medically important fungi on hospital fabrics and plastics. J Clin Microbiol 39(9):3360-3361, 2001
PubMed
13) Noskin GA et al:Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces. Infect Control Hosp Epidemiol 16(10):577-581, 1995
PubMed
14) Bean B et al:Survival of influenza viruses on environmental surfaces. J Infect Dis 146(1):47-51, 1982
PubMed
15) Hotchkiss JR et al:Analyzing pathogen transmission in the dialysis unit:time for a(schedule) change? Clin J Am Soc Nephrol 2(6):1176-1185, 2007
PubMed
16) Ohl M et al:Hospital privacy curtains are frequently and rapidly contaminated with potentially pathogenic bacreria. Am J Infect Contol 40(10):904-906, 2012
 
17) Shek K et al:Rate of contamination of hospital privacy curtains on a burns and plastic surgery ward:a cross-sectional study. J Hosp Infect 96(1):54-58, 2017
 
18) Shek K et al:Rate of contamination of hospital privacy curtains in a burns/plastic ward:a longitudinal study. Am J Infect Control 46(9):1019-1021, 2018
 
19) Luk S et al:Effectiveness of antimicrobial hospital curtains on reducing bacterial contamination-a multicenter study. Infect Control Hosp Epidemiol 40(2):164-170, 2019
PubMed
20) Nguyen DB et al:National healthcare safety network(NHSN) dialysis event surveillance report for 2014. Clin J Am Soc Nephrol 12(7):1139-1146, 2017
PubMed
21) Kumbar L et al:Current concepts in hemodialysis vascular access infections. Adv Chrinic Kidney Dis 26(1):16-22, 2019
 
22) Ravani P et al:Associations between hemodialysis access type and clinical outcomes:a systematic review. J Am Soc Nephrol 24(3):465-473, 2013
PubMed
23) Xue H et al:Hemodialysis access usage patterns in the incident dialysis year and associated catheter-related complications. Am J Kidney Dis 61(1):123-130, 2013
PubMed
24) Ocak G et al:Hemodialysis catheters increase mortality as compared to arteriovenous accesss especially in elderly patients. Nephrol Dial Transplant 26(8):2611-2617, 2011
 
25) Pastan S et al:Vascular access and increased risk of death among hemodialysis patients. Kidney Int 62(2):620-626, 2002
PubMed
26) Raad II et al:Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 5(4 Pt 1):231-238, 1994
 
27) Sherertz RJ et al:Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Int Med 132(8):641-648, 2000
PubMed
28) Carrer S et al:Effect of different sterile barrier precautions and central venous catheter dressing on the skin colonization around the insertion site. Minerva Anestesiol 71(5):197-206, 2005
PubMed
29) CDC:Guidelines for the prevention of intravascular catheter-related infections, 2011. http://www.cdc.gov/hicpac/pdf/guidelines/bsi-guidelines-2011.pdf
 
30) McCann M et al:Is 2% chlorhexidine gluconate in 70% isopropyl alcohol more effective at preventing central venous catheter-related infections than routinely used chlorhexidine gluconate solutions:A pilot multicenter randomized trial(ISRCTN2657745)? Am J Infect Control 44(8):948-949, 2016
PubMed
31) Rosenblum A et al:Hemodialysis catheter care strategies:a cluster-randomized quality improvement initiative. Am J Kidney Dis 63(2):259-267, 2014
PubMed
32) Mohamed H et al:Determinants and outcomes of access-related blood-stream infections among Irish haemodialysis patients;a cohort study. BMC Nephrol 20(1):68, 2019
PubMed
33) Oliver MJ et al:Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use:A prospective study. Kidney Int 58(6):2543-2545, 2000
PubMed
34) Parienti JJ et al:Femoral vs jugular venous catheterization and risk of nosocomical events in adults requiring acute renal replacement therapy:a randomized controlled trial. JAMA 299(20):2413-2422, 2008
 
35) Mermel LA et al:Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection:2009 Update by the Infectious Disease Society of America. Clin Infect Dis 49(1):1-45, 2009
 
36) Kumbar L et al:Current concepts in hemodialysis vascular access infections. Adv Chronic Kidney Dis 26(1):16-22, 2019
PubMed
37) Quittnat Pelletier F et al:Evaluating approaches for the diagnosis of hemodialysis catheter-related bloodstream infections. Clin J Am Soc Nephrol 11(5):847-854, 2016
PubMed
38) Aslam S et al:Systemic review and meta-analysis on management of hemodialysis catheter-related bacteremia. J Am Soc Nephrol 25(12):2927-2941, 2014
PubMed
39) Farrington CA et al:Management of the hemodialysis patient with catheter-related bloodstream infection. Clin J Am Soc Nephrol 14(4):611-613, 2019
PubMed
40) EI Nekidy WS et al:Salvage of hemodialysis catheter in Staphylococcal bacteremia:case series, revisiting the literature, and the role of the pharmacist. Case Rep Nephrol Dial 8(2):121-129, 2018
 
41) Suzuki M et al:Bacteremia in hemodialysis patients. Word J Nephrol 5(6):489-496, 2016
 
42) Peterson WJ et al:Treatment of dialysis catheter-related Enterococcus bacteremia with an antibiotic lock:a quality improvement report. Am J Kidney Dis 53(1):107-111, 2009
 
43) Maya ID et al:Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock:a quality improvement report. Am J Kidney Dis 50(2):289-295, 2007
 

第4章 透析室の病原体とその感染対策

P.100 掲載の参考文献
1) CDC:Guideline for infection control in health care personnel, 1998. https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/
 
2) CDC:Updated U.S. Public Health Service Guidelines for the management of occupational exposures to HBV, HCV, and HIV and Recommendations for postexposure prophylaxis, 2001. http://www.cdc.gov/mmwr/PDF/rr/rr5011.pdf
 
3) CDC:Recommendations for preventing transmission of infections among chronic hemodialysis patients, 2001. http://www.cdc.gov/mmwr/PDF/rr/rr5005.pdf
 
4) Branson BM et al:Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. https://www.cdc.gov/mmwr/PDF/rr/rr5514.pdf
 
5) DiNenno EA et al:Recommendations for HIV screening of gay, bisexual, and other men who have sex with men-United States, 2017. https://www.cdc.gov/mmwr/volumes/66/wr/pdfs/mm6631a3.pdf
 
6) 厚生労働省健康局結核感染症課長:後天性免疫不全症候群に関する特定感染症予防指針の改正に係る留意事項について. http://www.pref.saitama.lg.jp/a0701/kansen/kourousyou/documents/ryuuijikou.pdf
 
7) CDC:Prevention and control of influenza with vaccines:Recommendations of the Advisory Committee on Immunization Practices(ACIP), 2011. http://www.cdc.gov/mmwr/pdf/wk/mm6033.pdf
 
8) CDC:Updated norovirus outbreak management and disease prevention guidelines. http://www.cdc.gov/mmwr/pdf/rr/rr6003.pdf
 
9) CDC:Guideline for the prevention and control of norovirus gastroenteritis outbreaks in healthcare settings. https://www.cdc.gov/infectioncontrol/pdf/guidelines/norovirus-guidelines.pdf
 
10) 厚生労働省:2021年 結核登録者情報調査年報集計結果について. https://www.mhlw.go.jp/content/10900000/000981709.pdf
 
11) CDC:Guideline for isolation precautions:Preventing transmission of infectious agents in healthcare settings, 2007. https://www.cdc.gov/infectioncontrol/pdf/guidelines/isolation-guidelines.pdf
PubMed
12) CDC:Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection---United States, 2010. http://www.cdc.gov/mmwr/pdf/rr/rr5905.pdf
 
13) CDC:Management of multidrug-resistant organisms in healthcare settings, 2006. https://www.cdc.gov/infectioncontrol/pdf/guidelines/mdro-guidelines.pdf
 

第5章 医療従事者のワクチン・患者のワクチン

P.111 掲載の参考文献
1) CDC:Guideline for infection control in health care personnel, 1998. https://www.cdc.gov/infectioncontrol/guidelines/healthcare-personnel/index.html
 
2) CDC:A Comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. http://www.cdc.gov/mmwr/PDF/rr/rr5516.pdf
 
3) CDC:Recommendations for preventing transmission of infections among chronic hemodialysis patients. http://www.cdc.gov/mmwr/PDF/rr/rr5005.pdf
 
4) CDC:Guidelines for vaccinating kidney dialysis patients and patients with chronic kidney disease. http://www.cdc.gov/dialysis/PDFs/Vaccinating_Dialysis_Patients_and_Patients_dec2012.pdf
 
5) Stevens CE et al and the Dialysis Vaccine Trial Study Group:Hepatitis B vaccine in patients receiving hemodialysis:immunogenicity and efficacy. N Engl J Med 311(8):496-501, 1984
 
6) CDC:Prevention and control of seasonal influenza with vaccines:Recommendations of the Advisory Committee on Immunization Practices-United States, 2016-17 influenza season. http://www.cdc.gov/mmwr/volumes/65/rr/pdfs/rr6505.pdf
 
7) Heinonen OP et al:Immunization during pregnancy against poliomyelitis and influenza in relation to childhood malignancy. Int J Epidemiol 2(3):229-235, 1973
PubMed
8) Munoz FM et al:Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol 192(4):1098-1106, 2005
PubMed
9) de Gans J et al:Dexamethasone in adults with bacterial meningitis. N Engl J Med 347(20):1549-1556, 2002
PubMed
10) CDC:Guidelines for vaccinating kidney dialysis patients and patient wich chronic kidney disease, Last Reviewed, Jul 2015. https://www.cdc.gov/vaccines/pubs/downloads/dialysis-guide-2012.pdf
 

第6章 血液・体液曝露とその対策

P.124 掲載の参考文献
1) CDC:Updated U.S. Public Health Service Guidelines for the management of occupational exposures to HBV, HCV, and HIV and Recommendations for postexposure prophylaxis. http://www.cdc.gov/mmwr/PDF/rr/rr5011.pdf
 
2) CDC:A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. http://www.cdc.gov/mmwr/PDF/rr/rr5516.pdf
 
3) CDC:Testing and clinical management of health care personnel potentially exposed to hepatitis C virus-CDC Guidance, United States, 2020 https://www.cdc.gov/mmwr/volumes/69/rr/rr6906a1.htm
 
4) CDC:Occupationally acquired HIV infection among health care workers-United States, 1985-2013. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6353a4.htm
 
5) Updated US Public Health Service Guidelines for the management of occupational exposures to human immunodeficiency virus and Recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol 34(9):875-892, 2013
 
6) CDC:Hepatitis B virus:a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination:Recommendations of the Immunization Practices Advisory Committee (ACIP). https://www.cdc.gov/mmwr/preview/mmwrhtml/00033405.htm
 
7) CDC:Recommendations for the prevention and control of hepatitis C virus(HCV) infection and HCV-related chronic disease. https://www.cdc.gov/mmwr/preview/mmwrhtml/00055154.htm
 
8) CDC:Breastfeeding:Hepatitis B and C infections. http://www.cdc.gov/breastfeeding/disease/hepatitis.htm
 

第8章 透析室に必要な感染対策の啓発

P.135 掲載の参考文献
1) 一般社団法人日本環境感染学会 ワクチンに関するガイドライン改訂委員会:医療関係者のためのワクチンガイドライン第2版. 環境感染誌 29(Suppl III):S1-S14, 2014
 
2) Hou Y-c et al:The efficacy of COVID-19 vaccines in chronic kidney disease and kidney transplantation patients:a narrative review. Vaccines 9:885, 2021
 
3) Reddy S et al:Vaccunation in chronic kidney disease. Adv Chronic Kidney Dis 26(1):72-78, 2019
 
4) 大石和久:インフルエンザ感染症の診断とワクチン接種. 臨床透析 22(2):227-232, 2006
 
5) 前田貞亮ほか:血液透析患者のインフルエンザ対策. 透析医会誌 20(1):96-106, 2005
 
6) Chang YT et al:Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodiakysis patients. Vaccine 30(33):5009-5018, 2012
 
7) Gilbertson DT et al:Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int 63(2):738-743, 2003
 
8) Dinits-Pensy M et al:The use of vaccines in adult patients with renal disease. Am J Kidney Dis 46(6):997-1011, 2005
 
9) Bond TC et al:Mortality of dialysis patients according to influenza and pneumococcal vaccination status. Am J Kidney Dis 60(6):959-965, 2012
 
10) Wang IK et al:Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis:a population-based study. PLoS One 8(3):e58317, 2013
 
11) Sarnak MJ et al:Pulmonary infectious mortality among patients with end-stage renal disease. Chest 120(6):1883-1887, 2001
 
12) Guo H et al:Pneumonia in incident dialysis patients-the United States Renal Data System. Nephrol Dial Transplant 23(2):680-686, 2008
 
13) Kawasaki S et al:Clinical and microbiological evaluation of hemodialysis-associated pneumonia(HDAP):should HDAP be included in healthcare-associated pneumonia? J Infect Chemother 17(5):640-645, 2011
 
14) Gilbertson DT et al:The association of pneumococcal vaccination with hospitalization and mortality in hemodialysis patients. Nephrol Dial Transplant 26(9):2934-2939, 2011
 
15) 菊地 勘:新型コロナウイルスと血液透析(1)透析患者における新型コロナウイルスの総論-都内の感染状況と対策を含めて-. 透析会誌55(2):71-77, 2022
 
16) 吉藤 歩ほか:新型コロナウイルスに対する治療・予防(2)ワクチン. 透析会誌55(2)129-136, 2022
 

書評

最近チェックした商品履歴

Loading...